Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin M Gabel

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Genome Biology|October 7, 2024
APC mutations dysregulate alternative polyadenylation in cancerAustin M Gabel, Andrea E Belleville, James D Thomas, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
Elevated Cardiovascular Biomarkers Following Hypertensive Disorder of PregnancyAustin M Gabel, Lindsay Cheu, Mindy Pike, et al.
Pregnancy (Hoboken, N.J.)|April 16, 2026
Higher Levels of Cardiovascular Biomarkers Following Hypertensive Compared to Normotensive PregnancyAustin M Gabel, Lindsay Cheu, Mindy Pike, et al.
Cell Reports|September 1, 2021
Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genomePhoebe C R Parrish, James D Thomas, Austin M Gabel, et al.
Plos Genetics|August 16, 2024
An autoregulatory poison exon in Smndc1 is conserved across kingdoms and influences organism growthAndrea E Belleville, James D Thomas, Jackson Tonnies, et al.
Nature Communications|February 1, 2024
Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivoAustin M Gabel, Andrea E Belleville, James D Thomas, et al.
Plos One|April 30, 2025
Muscleblind-like proteins are novel modulators of the tumor-immune microenvironmentAustin M Gabel, Edie I Crosse, Andrea E Belleville, et al.
Elife|October 10, 2022
N-myc downstream regulated gene 1 (ndrg1) functions as a molecular switch for cellular adaptation to hypoxiaJong S Park, Austin M Gabel, Polina Kassir, et al.
Nature Genetics|January 9, 2020
RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exonsJames D Thomas, Jacob T Polaski, Qing Feng, et al.
Nature Biotechnology|March 4, 2022
Synthetic introns enable splicing factor mutation-dependent targeting of cancer cellsKhrystyna North, Salima Benbarche, Bo Liu, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Genome Biology|October 7, 2024
APC mutations dysregulate alternative polyadenylation in cancerAustin M Gabel, Andrea E Belleville, James D Thomas, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
Elevated Cardiovascular Biomarkers Following Hypertensive Disorder of PregnancyAustin M Gabel, Lindsay Cheu, Mindy Pike, et al.
Pregnancy (Hoboken, N.J.)|April 16, 2026
Higher Levels of Cardiovascular Biomarkers Following Hypertensive Compared to Normotensive PregnancyAustin M Gabel, Lindsay Cheu, Mindy Pike, et al.
Cell Reports|September 1, 2021
Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genomePhoebe C R Parrish, James D Thomas, Austin M Gabel, et al.
Plos Genetics|August 16, 2024
An autoregulatory poison exon in Smndc1 is conserved across kingdoms and influences organism growthAndrea E Belleville, James D Thomas, Jackson Tonnies, et al.
Nature Communications|February 1, 2024
Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivoAustin M Gabel, Andrea E Belleville, James D Thomas, et al.
Plos One|April 30, 2025
Muscleblind-like proteins are novel modulators of the tumor-immune microenvironmentAustin M Gabel, Edie I Crosse, Andrea E Belleville, et al.
Elife|October 10, 2022
N-myc downstream regulated gene 1 (ndrg1) functions as a molecular switch for cellular adaptation to hypoxiaJong S Park, Austin M Gabel, Polina Kassir, et al.
Nature Genetics|January 9, 2020
RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exonsJames D Thomas, Jacob T Polaski, Qing Feng, et al.
Nature Biotechnology|March 4, 2022
Synthetic introns enable splicing factor mutation-dependent targeting of cancer cellsKhrystyna North, Salima Benbarche, Bo Liu, et al.
Pageof 2